About scisparc ltd - SPRC
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It operates through the Drug Development and Online Sales segments. The Drug Development segment focuses on cannabinoid molecules to be approved by an official regulatory authority. The Online Sales segment consists of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.
SPRC At a Glance
SciSparc Ltd.
20 Raul Wallenberg Street
Tel Aviv, Tel Aviv 6971916
| Phone | 972-3-717-5777 | Revenue | 856.00K | |
| Industry | Pharmaceuticals: Major | Net Income | -12,179,000.00 | |
| Sector | Health Technology | Employees | 3 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
SPRC Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 197.303 |
| Price to Book Ratio | 0.117 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -19.443 |
| Enterprise Value to Sales | 193.405 |
| Total Debt to Enterprise Value | 0.002 |
SPRC Efficiency
| Revenue/Employee | 285,333.333 |
| Income Per Employee | -4,059,666.667 |
| Receivables Turnover | 4.057 |
| Total Asset Turnover | 0.095 |
SPRC Liquidity
| Current Ratio | 2.413 |
| Quick Ratio | 2.379 |
| Cash Ratio | 2.047 |
SPRC Profitability
| Gross Margin | 51.051 |
| Operating Margin | -1,022.079 |
| Pretax Margin | -1,409.346 |
| Net Margin | -1,422.78 |
| Return on Assets | -135.556 |
| Return on Equity | -196.546 |
| Return on Total Capital | -264.473 |
| Return on Invested Capital | -196.404 |
SPRC Capital Structure
| Total Debt to Total Equity | 8.634 |
| Total Debt to Total Capital | 7.948 |
| Total Debt to Total Assets | 4.802 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |